The GLP-1 analog liraglutide has been shown to reduce activated microglia and astroglia numbers, as well as pro-inflammatory cytokines IL-1β and TNF-α, in the brains of AD transgenic mice [52,53]. Here, GLP1R is linked to Alzheimer disease.